# reload+after+2024-01-22 12:38:15.305851
address1§1 New Burlington Place
city§London
zip§W1S 2HR
country§United Kingdom
phone§44 20 7399 2760
fax§44 20 7399 2761
website§https://www.hikma.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.
fullTimeEmployees§8700
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Mazen Samih Taleb Darwazah', 'age': 65, 'title': 'Executive Vice Chairman & President of MENA', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 1533331, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Riad  Mishlawi', 'title': 'Chief Executive Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Khalid Waleed Hosny Al Nabilsi', 'age': 51, 'title': 'Chief Financial Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Guy  Featherstone', 'title': 'Associate Director of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bassam Wael Rushdi Kanaan CFA, CPA', 'age': 58, 'title': 'Executive Vice President of Corporate Development and M&A', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Hussein Omar Arkhagha', 'title': 'Chief Human Resources Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susan  Ringdal', 'title': 'Executive Vice President of Strategic Planning & Global Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brian  Hoffmann', 'title': 'President of Generics', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Samuel  Park', 'title': 'Global Head of Intellectual Property (IP) & General Counsel for US', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. William  Larkins Ph.D.', 'title': 'President of Injectables Business', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§9
compensationRisk§3
shareHolderRightsRisk§6
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§0.49
dividendYield§0.026600001
exDividendDate§1691625600
payoutRatio§0.8279
fiveYearAvgDividendYield§1.96
beta§0.414
priceToSalesTrailing12Months§1.504905
currency§GBp
forwardEps§1.67
pegRatio§2.17
exchange§LSE
quoteType§EQUITY
shortName§HIKMA PHARMACEUTICALS PLC ORD S
longName§Hikma Pharmaceuticals PLC
firstTradeDateEpochUtc§1130832000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§fd537620-7ee9-3547-bfe6-854825fddff7
targetHighPrice§27.36
targetLowPrice§18.4
targetMeanPrice§22.42
targetMedianPrice§22.34
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§10
quickRatio§0.987
earningsGrowth§-0.223
grossMargins§0.49688998
ebitdaMargins§0.30135
trailingPegRatio§None
